Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa

Yiqiu Yao; Misbah Noshela Ghazanfar; Astrid Helene Ravn Jørgensen; Hans Christian Ring; Simon Francis Thomsen

doi:10.1159/000528139

Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa

Yiqiu Yao, Misbah Noshela Ghazanfar, Astrid Helene Ravn Jørgensen, Hans Christian Ring, Simon Francis Thomsen^*

^*Corresponding author af dette arbejde

Inflammation, Metabolism and Oxidation

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

7 Downloads (Pure)

Abstract

Increasing evidence suggests an association between chronic inflammatory conditions and oral health. Herein, we present a case of a 35-year-old woman with concomitant hidradenitis suppurativa (HS) and periodontitis, who was treated successfully with adalimumab. After 3 months of treatment, a marked improvement was observed in her clinical scores of HS, quality of life, as well as her gingival pain and signs of inflammation. This finding calls for a closer collaboration between dermatologists and dentists to further explore the possible beneficial role of biologic therapy for chronic inflammatory skin conditions as well as periodontitis.

Originalsprog	Engelsk
Tidsskrift	Case Reports in Dermatology
Vol/bind	15
Udgave nummer	1
Sider (fra-til)	5-9
ISSN	1662-6567
DOI	https://doi.org/10.1159/000528139
Status	Udgivet - 2023

Bibliografisk note

Publisher Copyright:
© 2023 The Author(s).

Adgang til dokumentet

10.1159/000528139Licens: CC BY-NC

FulltextForlagets udgivne version, 344 KBLicens: CC BY-NC

Citationsformater

@article{78018f268f59479581de2eb2cfb5faa2,

title = "Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa",

abstract = "Increasing evidence suggests an association between chronic inflammatory conditions and oral health. Herein, we present a case of a 35-year-old woman with concomitant hidradenitis suppurativa (HS) and periodontitis, who was treated successfully with adalimumab. After 3 months of treatment, a marked improvement was observed in her clinical scores of HS, quality of life, as well as her gingival pain and signs of inflammation. This finding calls for a closer collaboration between dermatologists and dentists to further explore the possible beneficial role of biologic therapy for chronic inflammatory skin conditions as well as periodontitis. ",

keywords = "Adalimumab, Hidradenitis suppurativa, Inflammation, Periodontitis",

author = "Yiqiu Yao and Ghazanfar, {Misbah Noshela} and J{\o}rgensen, {Astrid Helene Ravn} and Ring, {Hans Christian} and Thomsen, {Simon Francis}",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s).",

year = "2023",

doi = "10.1159/000528139",

language = "English",

volume = "15",

pages = "5--9",

journal = "Case Reports in Dermatology",

issn = "1662-6567",

publisher = "S Karger AG",

number = "1",

}

TY - JOUR

T1 - Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa

AU - Yao, Yiqiu

AU - Ghazanfar, Misbah Noshela

AU - Jørgensen, Astrid Helene Ravn

AU - Ring, Hans Christian

AU - Thomsen, Simon Francis

PY - 2023

Y1 - 2023

N2 - Increasing evidence suggests an association between chronic inflammatory conditions and oral health. Herein, we present a case of a 35-year-old woman with concomitant hidradenitis suppurativa (HS) and periodontitis, who was treated successfully with adalimumab. After 3 months of treatment, a marked improvement was observed in her clinical scores of HS, quality of life, as well as her gingival pain and signs of inflammation. This finding calls for a closer collaboration between dermatologists and dentists to further explore the possible beneficial role of biologic therapy for chronic inflammatory skin conditions as well as periodontitis.

AB - Increasing evidence suggests an association between chronic inflammatory conditions and oral health. Herein, we present a case of a 35-year-old woman with concomitant hidradenitis suppurativa (HS) and periodontitis, who was treated successfully with adalimumab. After 3 months of treatment, a marked improvement was observed in her clinical scores of HS, quality of life, as well as her gingival pain and signs of inflammation. This finding calls for a closer collaboration between dermatologists and dentists to further explore the possible beneficial role of biologic therapy for chronic inflammatory skin conditions as well as periodontitis.

KW - Adalimumab

KW - Hidradenitis suppurativa

KW - Inflammation

KW - Periodontitis

U2 - 10.1159/000528139

DO - 10.1159/000528139

M3 - Journal article

C2 - 36619701

AN - SCOPUS:85181688753

VL - 15

SP - 5

EP - 9

JO - Case Reports in Dermatology

JF - Case Reports in Dermatology

SN - 1662-6567

IS - 1

ER -